Presbyopia Therapies Announces Primary Safety and Efficacy Endpoints met in a Phase IIb study of its Topical PRX Ophthalmic Solution for the Treatment of Presbyopia
The Need for a Consensus
CTMS cloud application streamlines trial management and delivers end-to-end visibility of clinical trials on one platform
ZERVIATE was established in three randomized, double-masked, placebo-controlled, conjunctival antigen challenge (Ora-CAC®3 model of allergic conjunctivitis)
Ophthalmic Product Development Insights
Digging deeper into the types of patients who get dry eye and the situations that can bring it on.